ABSTRACT-The phosphatase inhibitor okadaic acid at 100 nM slowly but completely inhibited high K+-induced contraction in the rat aorta (t1/2=118.9 min). High K+-induced contraction was partially in hibited (to 37 65%) by 1 iM forskolin, 100 , tM dibutyryl cyclic AMP, 100 nM atrial natriuretic peptide, 1 1tM nitroglycerin, 10 nM sodium nitroprusside, 300 pM nicardipine or 100 nM verapamil. The rate of relaxa tion due to okadaic acid became faster when the contraction was partially inhibited by these compounds. Augmentation of the relaxation was greater with forskolin and dibutyryl cyclic AMP than with the other inhibitors. These results support the suggestion that okadaic acid inhibits phosphatase to augment the phosphorylation due to cyclic AMP-dependent kinase, resulting in smooth muscle relaxation.
Okadaic acid is a potent inhibitor of protein phos phatases, inhibiting type 2A phosphatase at lower concen trations and type 1 phosphatase at higher concentrations (1, 2) . In smooth muscle, okadaic acid has concentration dependent dual effects. At concentrations higher than 1 pM, okadaic acid induces contraction (3, 4) by phos phorylating the myosin light chain (5) . At lower concen trations, in contrast, okadaic acid inhibits contractions induced by high K+-depolarization and receptor agonists (6 8) . Since the characteristics of the inhibitory effect of okadaic acid are similar to those of cyclic AMP-related relaxants such as forskolin and dibutyryl cyclic AMP (db cAMP), it has been suggested that okadaic acid may in hibit phosphatases and thus increase the cyclic AMP-de pendent protein phosphorylation (6) . If this is the case, the effect of okadaic acid should be augmented when the cyclic AMP level is increased, and testing this hypothesis was the purpose of the present experiments.
Male Wistar rats (200-250 g) were killed by a sharp blow on the neck and exsanguination. The thoracic aorta was isolated and cut into transverse strips (2-mm-wide and 5-mm-long). Endothelium was removed by gently rub bing the intimal surface with a finger moistened with phys iological salt solution which contained 136.9 mM NaCl, 5.4 mM KCI, 1.5 mM CaC12, 1.0 MM MgC12, 23.8 mM NaHCO3, 0.01 mM ethylenediaminetetraacetic acid and 5.5 mM glucose. High K+ solution was made by substitut ing 60 mM NaC1 with equimolar KCI. These solutions were saturated with a 95% 02 and 5% CO2 mixture at 371C to maintain the pH at 7.4.
Okadaic acid was donated by Dr. D. Uemura, Shizu oka University and nitroglycerin, by Nippon Kayaku Co., Tokyo. Other chemicals used were forskolin, nicardipine, verapamil (Sigma Chemical Co., St. Louis, MO, USA); db-cAMP (Yamasa Shouyu, Tokyo); a-human atrial natriuretic peptide (Peptide Institute, Osaka); and sodi um nitroprusside (Wako Pure Chemicals, Osaka). Results of the experiments are shown by the mean±S.E.M. of the data.
Contractile force was measured with a force-displace ment transducer (Nihon Kohden, Tokyo). The muscle preparation was equilibrated for 30 min in a 10-ml bath. High K+ was applied three times, 10 min each, at a 15 min interval, before starting the experimental procedures. When the contractile force due to the fourth application of high K+ reached a steady level, okadaic acid was ad ded. As shown in Fig. IA , 100 nM okadaic acid slowly and completely relaxed the high K+-induced contraction. The time required to relax the contraction by 50% (half time or t172) was 118.9±5.5 min (n=12). Lower concen trations of okadaic acid inhibited the contraction more slowly 01/2>120 min), whereas a higher concentration (300 nM) more rapidly inhibited the contraction with a shorter t112 (58.9± 1.9 min, n=4). From these results, we decided to use t1/2 rather than contractile force as an indi cator of the inhibitory effect of okadaic acid. Previously, we have shown that the relaxant effects of forskolin and db-cAMP are inversely proportional to the magnitude of contractile tension; that is, the relaxant effect is greater when the contraction before the addition of the relaxant was smaller (9) . To examine if the inhibi tory effect of okadaic acid is also modified by the magni tude of contraction, we partially inhibited the high K+-in duced contraction by adding Ca 21 channel blockers. As shown in Fig. 1B , 100 nM verapamil was added during the high K+-induced contraction which inhibited the con traction to a new steady level of 36.5±2.7% (n=4). Then 100 nM okadaic acid was sequentially added. In the presence of verapamil, the rate of okadaic acid-induced relaxation became slightly faster. TI/2 was decreased by 19.2 min or to 85.0% of the t1,2 in the absence of ver apamil. Nicardipine (100 pM) showed a similar effect as verapamil, inhibiting the high K+-induced contraction to 52.7010 and decreasing t12 to 82.2±6.1010 (n=4). The relationship between the magnitude of contraction (T in Fig. 1 ) and potency of okadaic acid (t12 in Fig. 1 ) in Fig.  2 shows that the relaxant effect of okadaic acid is greater when the magnitude of contraction before the addition of okadaic acid was smaller. The similarity between the effects of okadaic acid and cyclic AMP-related vasodila tors supports the suggestion that okadaic acid inhibits phosphatase to augment the phosphorylation due to cyclic AMP-dependent kinase.
In the next experiments, we determined if the increase in cyclic AMP level further augments the effect of okadaic acid. To increase the cyclic AMP level, we added forsko lin or db-cAMP during the high K+-induced contraction. As shown in Fig. 1C , addition of 1 pM forskolin inhibit ed the high K+-induced contraction to 49.2--L6.1%
(n=4). In the presence of forskolin, the rate of okadaic acid-induced relaxation became faster and shortened t1/2 to 37.5±1.4010 (n=4). The effect of db-cAMP was similar to that of forskolin. The relationship between the magni tude of contraction (T in Fig. 1 ) and potency of okadaic acid (t12 in Fig. 1 ) is shown in Fig. 2 . The slope of the cor relation was steeper in the presence of cyclic AMP-related relaxants than in the presence of Ca2+ channel blockers, suggesting that the inhibitory potency of okadaic acid is greatly augmented when the cyclic AMP level is in creased.
To determine if the inhibitory effect of okadaic acid is selectively augmented by cyclic AMP, we examined the effects of cyclic GMP. To increase the cyclic GMP level, we used 10 nM sodium nitroprusside, 100 nM atrial natriuretic peptide and 1 pM nitroglycerin. As shown in Fig. 2 , these compounds inhibited the high K+-induced contraction to 45.4-64.7% and shortened t12 to 65.1 82.0% of the respective control level. The slope of the correlation for cyclic GMP-related relaxants is only slightly steeper than that for Ca 21 channel blockers, sug gesting that cyclic GMP has only a small, if any, potentiat ing effect on okadaic acid-induced relaxation. It is general ly believed that cyclic GMP activates protein kinase to phosphorylate functional proteins and relaxes smooth muscle. However, the site of action of cyclic GMP seems to be different from that of cyclic AMP because cyclic GMP relaxes smooth muscle with little effect on myosin phosphorylation (11), and cyclic AMP but not cyclic GMP augmented the effect of okadaic acid (present result). It is possible that okadaic acid inhibits the phos phatase antagonizing the cyclic AMP-dependent kinase with little effect on the phosphatase antagonizing the cyclic GMP-dependent kinase.
In the rat aorta, the major mechanism of the effect of cyclic AMP on high K+-induced contraction is to decrease the Ca 21 sensitivity of contractile elements without changing the cytosolic Ca2+ level (9) . Cyclic AMP has been shown to inhibit myosin phosphorylation to relax smooth muscle (10). This effect may be an tagonized by the increase in cytosolic Ca 21 (9) , and this may be the reason why the relaxant effect of cyclic AMP is stronger on a smaller contraction (or in the presence of lower cytosolic Ca2+ level). In the present experiments, we found that the inhibitory effect of okadaic acid is also stronger when the contraction was partially inhibited by Ca 2+ channel blockers or nitro-vasodilators. Further more, the inhibitory effect of okadaic acid was more strongly augmented when the contraction was partially inhibited by cyclic AMP-related relaxants. These results support the suggestion that okadaic acid inhibits phos phatases and thus augments cyclic AMP-dependent phos phorylation to induce vasodilation. This effect may be an tagonized by the increase in cytosolic Ca 2+ level and aug mented by the increase in cyclic AMP level.
